These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15900109)

  • 1. Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome.
    van Pareren YK; Duivenvoorden HJ; Slijper FM; Koot HM; Drop SL; de Muinck Keizer-Schrama SM
    Horm Res; 2005; 63(5):238-44. PubMed ID: 15900109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial functioning, self-perception and body image and their auxologic correlates in growth hormone and oestrogen-treated young adult women with Turner syndrome.
    Lagrou K; Froidecoeur C; Verlinde F; Craen M; De Schepper J; François I; Massa G;
    Horm Res; 2006; 66(6):277-84. PubMed ID: 16946621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Massa GG; Rouwe CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4607-12. PubMed ID: 10599727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age.
    van Pareren YK; Duivenvoorden HJ; Slijper FS; Koot HM; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5295-302. PubMed ID: 15531473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Visser M; Kreukels BP; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM; Cohen-Kettenis PT
    Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related perception of stature, acceptance of therapy, and psychosocial functioning in human growth hormone-treated girls with Turner's syndrome.
    Lagrou K; Xhrouet-Heinrichs D; Heinrichs C; Craen M; Chanoine JP; Malvaux P; Bourguignon JP
    J Clin Endocrinol Metab; 1998 May; 83(5):1494-501. PubMed ID: 9589645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome.
    Bannink EM; Raat H; Mulder PG; de Muinck Keizer-Schrama SM
    J Pediatr; 2006 Jan; 148(1):95-101. PubMed ID: 16423606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
    Bannink EM; van Sassen C; van Buuren S; de Jong FH; Lequin M; Mulder PG; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):265-73. PubMed ID: 19200215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age.
    Hokken-Koelega A; van Pareren Y; Arends N
    Horm Res; 2005; 64 Suppl 3():95-9. PubMed ID: 16439851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial.
    Sas TC; Gerver WJ; de Bruin R; Stijnen T; de Muinck Keizer-Schrama SM; Cole TJ; van Teunenbroek A; Drop SL
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4622-8. PubMed ID: 10599729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences.
    Bannink EM; van der Palen RL; Mulder PG; de Muinck Keizer-Schrama SM
    Horm Res; 2009; 71(6):343-9. PubMed ID: 19506392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychological consequences of Turner syndrome and review of the National Cooperative Growth Study psychological substudy.
    Siegel PT; Clopper R; Stabler B
    Pediatrics; 1998 Aug; 102(2 Pt 3):488-91. PubMed ID: 9685450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Aanstoot HJ; Drop SL
    J Clin Endocrinol Metab; 2000 Feb; 85(2):769-75. PubMed ID: 10690889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; van Koningsbrugge SH; de Ridder MA; Zandwijken GR; Boersma B; Dejonckere PH; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
    Binder G; Trebar B; Baur F; Schweizer R; Ranke MB
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turner syndrome, insulin sensitivity and growth hormone treatment.
    Mazzanti L; Bergamaschi R; Castiglioni L; Zappulla F; Pirazzoli P; Cicognani A
    Horm Res; 2005; 64 Suppl 3():51-7. PubMed ID: 16439845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.